Clinical Report: Rethinking UK Glaucoma Care

Overview

Glaucoma is a leading cause of irreversible sight loss in the UK, affecting over one million people. Evidence suggests that optometry-led referral filtering services can significantly reduce hospital waiting lists and improve patient care.

Background

Glaucoma is the second leading cause of irreversible sight loss in the UK, with projections indicating a rise in cases to 1.145 million by 2030. The burden on ophthalmology services is substantial, with glaucoma accounting for 20-25% of outpatient activity. Effective management strategies, such as optometry-led services, are essential to address the increasing demand and improve patient outcomes.

Data Highlights

No numerical data provided in the source material.

Key Findings

• Glaucoma affects over one million people in the UK, with a projected increase of 100,000 cases by 2030.
• Glaucoma accounts for 20-25% of hospital eye services outpatient activity, contributing to significant waiting lists.
• 40% to 75% of new glaucoma referrals to hospitals could be prevented with effective glaucoma referral filtering services.
• Patient satisfaction is high with optometry-led services, reporting shorter waiting times and better communication.
• Community shared care pathways for low-risk glaucoma patients should be universally adopted across the UK.

Clinical Implications

Healthcare policymakers are urged to expand optometry-led glaucoma referral filtering services and community shared care pathways to enhance patient care. This approach can alleviate pressure on hospital services and improve access to timely glaucoma management.

Conclusion

The implementation of optometry-led services and shared care pathways is crucial for improving glaucoma care in the UK. A coordinated approach can help prevent avoidable sight loss and support an aging population.

References

1. The College of Optometrists, College of Optometrists, 2023 -- Rethinking UK Glaucoma Care
2. Ophthalmology Management — When is Glaucoma “Controlled”? Recommendations
3. Glaucoma Physician — Glaucoma in Africa
4. Glaucoma Physician — When is Glaucoma “Controlled”?
5. Glaucoma Physician — Individualizing Glaucoma Medical Management
6. NICE Guidance on Glaucoma Management
7. When is Glaucoma “Controlled”? Recommendations
8. Glaucoma in Africa
9. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial - PubMed